Former Chief Medical Officer, Immuno-oncology · BeOne Medicines Ltd. (ONC)

Amy Peterson

A named executive officer of BeOne Medicines in every fiscal year CompBrief holds from FY2017 to FY2019. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$1,427,242

Salary $37,051Stock awards $0

FY2018: $3,395,584

5th of 5 named executive officers at BeOne Medicines by FY2019 total.

5 named officers on file for BeOne Medicines, FY2019

Amy Peterson’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 2 equity grants, each cited to its filing
  • ONC’s disclosed peer group of 15 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how BeOne Medicines’s whole pay program stands against its peers

  • BeOne Medicines’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ONC→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2020 (DEF 14A).

Free

Get Amy Peterson’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Amy Peterson compensation by year

BeOne Medicines Summary Compensation Table · all 3 fiscal years held
In US dollars, as BeOne Medicines reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019
Salary$400,000$425,000$37,051
Bonus$224,000$0$0
Stock awards$0$549,851$0
Option awards$2,478,255$2,199,983$938,537
Non-equity incentive$0$212,500$0
Pension and deferred compensation$0$0$0
All other$8,100$8,250$451,654
Total$3,110,355$3,395,584$1,427,242

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BeOne Medicines Ltd. DEF 14A filed April 28, 2020, accession 0001047469-20-002658, and prior-year filings. Open the filing on EDGAR.

How this page was built: the BeOne Medicines Ltd. filed document, accession 0001047469-20-002658. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2020.

$3.1M
$3.4M
$1.4M
FY17
FY18
FY19
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

BeOne Medicines’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
John OylerFounder, Chief Executive Officer and Chairman$12,575,474
Xiaobin WuGeneral Manager of China and President$9,127,396
Howard LiangChief Financial Officer and Chief Strategy Officer$4,194,547
Jane HuangChief Medical Officer, Hematology$3,605,347
Amy Peterson · this pageFormer Chief Medical Officer, Immuno-oncology$1,427,242

The full BeOne Medicines compensation record

free company brief

This page is one person within BeOne Medicines's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are BeOne Medicines's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Amy Peterson's compensation dossier · One-time report. No refunds.